Scientists advise Pfizer to wait until November to seek FDA authorisation for its COVID-19 vaccine

A team of more than 60 scientists and bioethicists have signed a letter urging Pfizer to wait until late November before the company seeks FDA authorization of its COVID-19 vaccine candidate, in an effort to ensure rigorous safety standards have been met.

Source:

Biospace Inc.